Clinical Trial

A Study of STAR-0310 in Healthy Adult Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 4, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, placebo-controlled, single ascending dose trial evaluating the safety, tolerability, PK, and immunogenicity of STAR-0310 in healthy adult participants. There are 4 planned cohorts and potentially up to 1 additional cohort which may comprise of healthy adult participants of Japanese descent.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-15.
Status change: Recruiting → Active, Not Recruiting 2025-10-31
Trial Details
NCT Number NCT06782477
Lead Sponsor Astria Therapeutics, Inc.
Conditions Healthy Participants
Enrollment 40 participants
Start Date 2025-01-07
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-04